In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods
- PMID: 23263007
- PMCID: PMC3591909
- DOI: 10.1128/AAC.01875-12
In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods
Abstract
Aspergillus fumigatus biofilms represent a problematic clinical entity, especially because of their recalcitrance to antifungal drugs, which poses a number of therapeutic implications for invasive aspergillosis, the most difficult-to-treat Aspergillus-related disease. While the antibiofilm activities of amphotericin B (AMB) deoxycholate and its lipid formulations (e.g., liposomal AMB [LAMB]) are well documented, the effectiveness of these drugs in combination with nonantifungal agents is poorly understood. In the present study, in vitro interactions between polyene antifungals (AMB and LAMB) and alginate lyase (AlgL), an enzyme degrading the polysaccharides produced as extracellular polymeric substances (EPSs) within the biofilm matrix, against A. fumigatus biofilms were evaluated by using the checkerboard microdilution and the time-kill assays. Furthermore, atomic force microscopy (AFM) was used to image and quantify the effects of AlgL-antifungal combinations on biofilm-growing hyphal cells. On the basis of fractional inhibitory concentration index values, synergy was found between both AMB formulations and AlgL, and this finding was also confirmed by the time-kill test. Finally, AFM analysis showed that when A. fumigatus biofilms were treated with AlgL or polyene alone, as well as with their combination, both a reduction of hyphal thicknesses and an increase of adhesive forces were observed compared to the findings for untreated controls, probably owing to the different action by the enzyme or the antifungal compounds. Interestingly, marked physical changes were noticed in A. fumigatus biofilms exposed to the AlgL-antifungal combinations compared with the physical characteristics detected after exposure to the antifungals alone, indicating that AlgL may enhance the antibiofilm activity of both AMB and LAMB, perhaps by disrupting the hypha-embedding EPSs and thus facilitating the drugs to reach biofilm cells. Taken together, our results suggest that a combination of AlgL and a polyene antifungal may prove to be a new therapeutic strategy for invasive aspergillosis, while reinforcing the EPS as a valuable antibiofilm drug target.
Figures




Similar articles
-
Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms.Int J Antimicrob Agents. 2015 Sep;46(3):342-5. doi: 10.1016/j.ijantimicag.2015.03.006. Epub 2015 Apr 24. Int J Antimicrob Agents. 2015. PMID: 25979638
-
3,5-Dicaffeoylquinic Acid Disperses Aspergillus Fumigatus Biofilm and Enhances Fungicidal Efficacy of Voriconazole and Amphotericin B.Med Sci Monit. 2018 Jan 22;24:427-437. doi: 10.12659/msm.908068. Med Sci Monit. 2018. PMID: 29356802 Free PMC article.
-
Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus.Antimicrob Agents Chemother. 2006 Mar;50(3):868-73. doi: 10.1128/AAC.50.3.868-873.2006. Antimicrob Agents Chemother. 2006. PMID: 16495244 Free PMC article.
-
Aspergillus fumigatus biofilms: Toward understanding how growth as a multicellular network increases antifungal resistance and disease progression.PLoS Pathog. 2021 Aug 26;17(8):e1009794. doi: 10.1371/journal.ppat.1009794. eCollection 2021 Aug. PLoS Pathog. 2021. PMID: 34437655 Free PMC article. Review.
-
Aspergillus fumigatus biofilms in the clinical setting.Med Mycol. 2011 Apr;49 Suppl 1:S96-S100. doi: 10.3109/13693786.2010.502190. Epub 2011 Jan 24. Med Mycol. 2011. PMID: 21254964 Review.
Cited by
-
Modulated Response of Aspergillus fumigatus and Stenotrophomonas maltophilia to Antimicrobial Agents in Polymicrobial Biofilm.Front Cell Infect Microbiol. 2020 Oct 6;10:574028. doi: 10.3389/fcimb.2020.574028. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33123497 Free PMC article.
-
Human monoclonal antibody-based therapy in the treatment of invasive candidiasis.Clin Dev Immunol. 2013;2013:403121. doi: 10.1155/2013/403121. Epub 2013 Jun 26. Clin Dev Immunol. 2013. PMID: 23878583 Free PMC article. Review.
-
Rhamnolipid exhibits anti-biofilm activity against the dermatophytic fungi Trichophyton rubrum and Trichophyton mentagrophytes.Biotechnol Rep (Amst). 2020 Aug 19;27:e00516. doi: 10.1016/j.btre.2020.e00516. eCollection 2020 Sep. Biotechnol Rep (Amst). 2020. PMID: 32884912 Free PMC article.
-
Recent progress on engineering microbial alginate lyases towards their versatile role in biotechnological applications.Folia Microbiol (Praha). 2020 Dec;65(6):937-954. doi: 10.1007/s12223-020-00802-8. Epub 2020 Jun 4. Folia Microbiol (Praha). 2020. PMID: 32500437 Review.
-
Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs.Microbiol Spectr. 2015 Jun;3(3):E30. doi: 10.1128/microbiolspec.MB-0008-2014. Microbiol Spectr. 2015. PMID: 26397003 Free PMC article.
References
-
- O'Toole G, Kaplan HB, Kolter R. 2000. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54:49–79 - PubMed
-
- Ramage G, Rajendran R, Gutierrez-Correa M, Jones B, Williams C. 2011. Aspergillus biofilms: clinical and industrial significance. FEMS Microbiol. Lett. 324:89–97 - PubMed
-
- Beauvais A, Schmidt C, Guadagnini S, Roux P, Perret E, Henry C, Paris S, Mallet A, Prévost MC, Latgé JP. 2007. An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell. Microbiol. 9:1588–1600 - PubMed
-
- Loussert C, Schmitt C, Prevost MC, Balloy V, Fadel E, Philippe B, Kauffmann-Lacroix C, Latgé JP, Beauvais A. 2010. In vivo biofilm composition of Aspergillus fumigatus. Cell. Microbiol. 12:405–410 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous